Aeon raises €8.2M in a seed round to enhance preventive healthcare with full-body check-ups, making it accessible to the masses.
Aeon raises €8.2M in a seed round to enhance preventive healthcare with full-body check-ups, making it accessible to the masses.
06/04/25, 4:25 AM
Location
winterthurMoney raised
€8.2 million
Industry
therapeutics
biotechnology
health care
Round Type
seed
Swiss preventative health company Aeon has closed a €8.2 million seed round for its platform for early detection and preventive healthcare. Aeon integrates full-body MRI, advanced blood biomarkers, and genetic insights into a single 60-minute check-up. They have maintained a 0 per cent false positive rate, a critical differentiator in a field plagued by overdiagnosis. The company’s technology aims to enable early detection of over 500 diseases and health risks.
Company Info
Location
winterthur, zurich, switzerland
Additional Info
Aeon is the first multi-modal preventive health platform designed to transform healthcare from reactive to proactive.
By combining whole-body MRI with blood data, genetic data, and more, we can detect diseases early and predict health risks with unprecedented accuracy. AI not only boosts diagnostic precision but also helps us reduce costs, making cutting-edge preventive care accessible to everyone.